Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Argus Boosts Amgen Target Price to $460 Amid Strong Earnings

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen's (NASDAQ:AMGN) stock price has been given a boost by analysts at Argus, who have increased their target price from $375.00 to $460.00.

This suggests a potential upside of 6.63% from the company's current price. The brokerage currently holds a 'buy' rating on Amgen's stock.

In addition to Argus, other firms such as Canaccord Genuity Group and BMO Capital Markets have also increased their target prices for Amgen in recent weeks.

More on Stocks

Stocks just now

IBM Sees Rebound After Q2 Software Sales Shortfall

Stocks 1m ago

Amazon Stock Hits Fresh Low as AI Spending Raises Cash Flow Concerns

Stocks 2m ago

McDonald's Data Center Debate Set for Packed Village Council Meeting

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy